NFKB1 and chronic obstructive pulmonary disease: In lung diseases, elevated or prolonged NF-κB activation is detected in the lungs of patients with asthma, chronic obstructive pulmonary disease (COPD), and silicosis (Wright and Christman, 2003; Di Giuseppe et al., 2009; Edwards et al., 2009).